The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus

Simranjeet Kaur, Aashiq H. Mirza, Caroline Anna Brorsson, Tina Fløyel, Joachim Størling, Henrik B. Mortensen, Flemming Pociot, Hvidoere International Study Group

25 Citationer (Scopus)

Abstract

The study aimed to explore the role of ERBB3 in type 1 diabetes (T1D). We examined whether genetic variation of ERBB3 (rs2292239) affects residual β-cell function in T1D cases. Furthermore, we examined the expression of ERBB3 in human islets, the effect of ERBB3 knockdown on apoptosis in insulin-producing INS-1E cells and the genetic and regulatory architecture of the ERBB3 locus to provide insights to how rs2292239 may confer disease susceptibility. rs2292239 strongly correlated with residual β-cell function and metabolic control in children with T1D. ERBB3 locus associated lncRNA (NONHSAG011351) was found to be expressed in human islets. ERBB3 was expressed and down-regulated by pro-inflammatory cytokines in human islets and INS-1E cells; knockdown of ERBB3 in INS-1E cells decreased basal and cytokine-induced apoptosis. Our data suggests an important functional role of ERBB3 and its potential regulators in the β-cells and may constitute novel targets to prevent β-cell destruction in T1D.

OriginalsprogEngelsk
TidsskriftMolecular and Cellular Endocrinology
Vol/bind419
Sider (fra-til)83-91
Antal sider9
ISSN0303-7207
DOI
StatusUdgivet - 5 jan. 2016

Fingeraftryk

Dyk ned i forskningsemnerne om 'The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus'. Sammen danner de et unikt fingeraftryk.

Citationsformater